EP1781804A1 - Procede et dispositif de mesure d'une activite enzymatique dans un fluide biologique - Google Patents
Procede et dispositif de mesure d'une activite enzymatique dans un fluide biologiqueInfo
- Publication number
- EP1781804A1 EP1781804A1 EP05796245A EP05796245A EP1781804A1 EP 1781804 A1 EP1781804 A1 EP 1781804A1 EP 05796245 A EP05796245 A EP 05796245A EP 05796245 A EP05796245 A EP 05796245A EP 1781804 A1 EP1781804 A1 EP 1781804A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- denotes
- substrate
- enzymatic activity
- electroactive
- electrode
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/46—Means for regulation, monitoring, measurement or control, e.g. flow regulation of cellular or enzymatic activity or functionality, e.g. cell viability
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
Definitions
- the invention relates to the field of biological analyzes and more particularly relates to a method and a device for measuring an enzymatic activity in a biological fluid, especially in whole blood.
- plasma preparation requires a number of pre-analytical steps and is also a source of potential errors.
- This patent describes more particularly a method for assaying proteases and anti-proteases, and in particular proteases and anti-proteases of the coagulation and complement systems.
- This process consists in reacting the enzyme to be assayed on an electrochemically neutral substrate but which, after hydrolysis by the enzyme, produces a hydrolysis product capable of being either oxidized or electrochemically reduced in the electro-electrochemical field. - Activity of the system, this product is then determined by amperometry at a pH between 6 and 10.
- the dosage of the enzyme is carried out here by a particular electrical measurement, defined in the patent.
- a particular example of the substrate used is benzoyl-D, L-arginyl-p-aminodiphenylamide chloride.
- the enzymatic reaction then makes it possible to release the corresponding amine, namely lap-aminodiphenylamine, also called pAD ⁇ , by abbreviation.
- this known method of assaying and measuring coagulation proteases and protease proteases is carried out only in a homogeneous medium, ie in solution.
- Patent EP 1 031 830 in the name of ASULAB, is largely based on the electrochemical sensor principle of US Pat. No. 4,304,853 mentioned previously.
- ASULAB proposes to measure the prothrombin time by measuring the electrical activity generated by an enzymatic reaction with a charged generator-generated electrolytic substrate that can be cut from its chain by thrombin.
- the surface on which the substrate is fixed is a platinum or silver layer.
- reaction is carried out in a homogeneous medium, that is to say in solution.
- the publication WO 01/36666 of the company I-STAT relates to an apparatus for the measurement of coagulation using an electrochemical sensor.
- the equipment uses a reagent to trigger a coagulation reaction. Sensors then directly measure the enzymatic activity responsible for coagulation.
- reaction described in the patent is a reaction in a homogeneous medium, that is to say in solution.
- the invention aims in particular to improve the situation by proposing a new method and a new device for measuring an enzymatic activity in a biological fluid, which avoids the disadvantages of the prior art. It is in particular an object of the invention to provide such a method and such a device which are suitable for the measurement of different enzymatic activities in biological fluids of various natures, and in particular in turbid and / or colored biological fluids, as is the case with whole blood.
- the invention more particularly relates to a method for measuring an enzymatic activity in a biological fluid, which comprises the following operations:
- the invention thus makes it possible to reveal an electroactive product serving as a marker and which can be released from the support or remain attached to the support, the quantity of which provides a direct measurement of the enzymatic activity by amperometry.
- - substrate molecule recognized and transformed by the enzyme
- marker the product of an enzymatic reaction which is an electroactive group detectable by an electrode
- micro or submicrovolumetric typically less than 100 microliters
- the substrate is deposited in the form of at least one monomolecular layer of molecules corresponding to one of the following general formulas I and II:
- S denotes a chemical group capable of forming a bond with the conductive surface
- C n denotes a methylenic aliphatic chain consisting of n carbon atoms
- E denotes a non-electroactive hydrophilic spacer of the polyethylene glycol type, optionally present to complete the C n chain,
- P denotes a polypeptide sequence specific for the enzymatic activity to be measured
- X denotes an electroactive residue capable of being oxidized or reduced in a range of potential accessible in the medium.
- n is an integer from 9 to 18.
- the conductive surface of the support is modified by deposition of a monomolecular layer or monomolecular strata of molecules corresponding to one or other of the general formulas I and II mentioned above.
- These molecules have the property of self-assembling spontaneously on the conductive surface. They are also called SAM, abbreviation of the English expression “SELF-ASSEMBLED MONOLAYERS” which means “self-assembled monolayers”.
- the hydrophilic spacer E is optional. Its insertion in the sequence of formula I or of formula II is useful for increasing the surface hydrophilicity of the substrate, on the solution side, thus reducing possible phenomena of short-range repulsion, irreversible adsorption or denaturation of the substrate. the enzyme as it approaches the surface.
- S denotes a thiol group
- C n denotes a hydrophobic carbon chain comprising n hydrocarbon chains, in particular methylene, and supporting a hydrophilic spacer
- E denotes a peptide sequence, at least two amino acids of a substrate specific for the enzymatic activity to be measured
- X is an aromatic amine, in particular para-aminodiphenylamide.
- S thus denotes a thiol group, also called sulfhydryl, connected to a carbon chain comprising n methylene chains (n is typically of the order of ten) and supporting a hydrophilic spacer E.
- n is typically of the order of ten
- E hydrophilic spacer
- P denotes a peptide sequence having at least two amino acids, typically between two and five amino acids. This peptide is chosen for its character of specificity with respect to the enzyme to be measured, for example thrombin, in the case of the measurement of an activity related to the coagulation of blood.
- X is advantageously an aromatic amine, in particular para-aminodiphenylamide.
- Enzymatic hydrolysis reveals the corresponding amine, p-amino diphenylamine.
- This amine was chosen for its appreciable hydrophobicity. This property favors the sensitivity of the detection insofar as it increases the partition coefficient: concentration of the free amine in the substrate / concentration of the free amine in solution.
- the amine is oxidized at low potentials, which makes it readily detectable in the presence of also oxidizable interferers, such as ascorbic acid.
- the invention is of particular interest in the case where the biological fluid is a cloudy fluid and / or colored, as is the case of whole blood.
- the enzymatic activity to be measured may be that of a coagulation factor or the complement of whole blood, in particular of a coagulation factor such as thrombin.
- enzymatic activity can be used to assay an endogenous or exogenous blood coagulation inhibitor or co-factor, knowing that the factors and inhibitors may be physiological or exogenous.
- Exogenous inhibitors include, in particular, heparin, a substance administered to patients to inhibit blood clotting.
- a drop of the sample in particular whole blood
- the substrate in particular an active sensor, the place of measurement, allows a rapid and direct detection of enzymatic activities sought.
- the invention makes it possible to avoid all the conventional pre-analytical steps necessary for the preparation of the plasma, which saves time and eliminates sources of errors. potential.
- the invention makes it possible to measure an enzymatic activity from a sample of small volume of the biological fluid.
- the enzyme that is to be quantified reacts with the immobilized substrate.
- This enzymatic reaction generates an electro-active product detected by the measuring electrode integrated in the sensor.
- the amplitude of the measured signal is proportional to the amount of product formed during the reaction, which makes it possible to know the activity of the coagulation factor.
- This measurement system can be used directly by the patient or through a hospital staff.
- One of the advantages of the invention is to allow a very rapid measurement of enzymatic activities, for example coagulation factors or coagulation inhibitors.
- the invention is therefore particularly applicable in emergency rooms as a rapid diagnostic tool, or in the patient, to measure the evolution of a specific enzymatic activity.
- the conductive surface is advantageously a layer of a metal capable of immobilizing the covalent molecules (I) or (II), in particular gold.
- a metal capable of immobilizing the covalent molecules (I) or (II), in particular gold.
- it is a layer of gold deposited on a support based on silicon.
- the detection operation is performed with electrodes which typically include a working electrode, a counter electrode and optionally a reference electrode.
- the working electrode is advantageously constituted by the support itself.
- the counter electrode and the reference electrode may be distinct; however, it is advantageous that the counter-electrode and the reference electrode are combined, the counter electrode then serving as a potential reference.
- the detection operation advantageously comprises the measurement of the amplitude of a signal proportional to the quantity of electro-active product revealed during the enzymatic reaction.
- the invention relates to a device for measuring an enzymatic activity in a biological fluid, which can be used for carrying out the method defined above.
- This device essentially comprises:
- the substrate is advantageously deposited in the form of at least one monomolecular layer of molecules corresponding to one or other of the general formulas I and II as mentioned above. Therefore, the characteristics defined previously for the method also apply to the device.
- the amperometric detection means comprise a specific potentiostat to deliver between the working electrodes and the reference electrode a periodic and adjustable potential difference to the detection domain of the marker.
- FIG. 1 is the structural formula of an example of a substrate according to the invention.
- FIG. 2 represents the structural formula of the peptide sequence of the substrate of FIG. 1;
- FIG. 3 is a perspective view of an electrode according to the invention.
- FIG. 4 is a perspective view of a measuring cell used in the invention.
- FIG. 5 represents the amperometric detection of p-aminodiphenylamine (pADA) in solution by a surface of gold modified by a monolayer of the substrate whose formula is represented in FIG. 1;
- pADA p-aminodiphenylamine
- FIG. 6 represents the gradual variation of a voltammetric current recorded during a kinetics of hydrolysis in the presence of 80 mU / ml of trypsin; and
- FIG. 7 is a graph showing the evolution of the currents of FIG. 6 as a function of time.
- Trypsin is a protease in the same way as the enzymes of hemostasis. Trypsin is a protease in the same way as the enzymes of hemostasis.
- the system used comprises a conductive surface, preferably a noble metal such as gold, modified by deposition of a monomolecular layer or monomolecular strata of molecules corresponding to one or other of the general formulas I and II such than previously mentioned.
- S is a thiol group (also called sulfhydryl)
- C n is a carbon chain comprising eleven methylene linkages
- E is a hydrophilic spacer of the hexa-ethylene glycol type
- P is a tripeptide sequence of a substrate hydrolyzed by the trypsin (the formula is shown in Figure 2)
- X is para-aminodiphenylamide.
- the amine which will be released by erizymatic hydrolysis namely p-aminodiphenylamine, was chosen because of its appreciable hydrophobicity, as mentioned above.
- This amine is oxidized at low potentials, which makes it readily detectable in the presence of interfering also oxidizable, such as ascorbic acid.
- This surface is a rectangular bar 1 (see Figure 3) having a surface layer of gold 2 deposited on a titanium layer 3, itself deposited on a strip 4 based on silicon.
- the gold layer has a thickness of 3000 Angstroms, the titanium layer 300 Angstrom and the silicon bar 500 microns.
- the whole is annealed for twenty minutes at 250 ° C. under vacuum.
- the process is carried out according to the usual techniques of elaboration of information media in microcomputer or microelectronics.
- SAM self-assembled monolayer
- the surface handled with non-paraffinized protective gloves, is carefully degreased with acetone, then with ethanol, then rinsed with ultra pure water, again with ethanol and finally dried under a stream of nitrogen. It is then used as a working electrode in a conventional three-electrode electrochemical assembly (working electrode, counter-electrode and reference electrode) and immersed in a solution of pure water containing 0.5% by volume of sulfuric acid.
- the i / E curve (current / potential) then reveals a series of peaks attributed to the formation of gold oxides in the region 1.2-1.5 V followed, after inversion of the potential, of a peak
- the integration of the reduction peak makes it possible to evaluate the effective surface of the electrode and therefore, in comparison with the geometrical surface, the roughness.
- the electrode is removed from the solution to a final potential of 0.0 V leaving the gold free of oxides detrimental to SAM formation, as described in the literature.
- the deposition of the assembled monolayer will now be described.
- the strip After vigorous rinsing with ultra pure water, the strip is left stirring and at room temperature for at least twelve hours in 10 ml of ethanol containing a homogeneous mixture of electrogenic substrate and mercapto-hexanol coupled to a polyethylene chain.
- C 3 glycol in a proportion of between 0.1 and 10% respectively calculated to obtain a total concentration of 0.1 mM.
- the mercapto-hexanol acts as a diluent of the substrate of FIG. 1 on the surface.
- electrochemical desorption this method consists of subjecting the modified surface to a reduction potential sweep from 0 to -1.4 V in 0.5 M KOH medium at 0.05 V / s. Under these conditions, each set of bonds (Au-S) present on the surface undergoes an electrochemical reduction which results in the desorption of the organic molecule. This reaction consumes electrons. There is therefore a peak of desorption whose potential is characteristic of each thiol. Integration of the peak gives the surface density of the thiol.
- the immobilized electrogenic substrate has an oxidation signal located above 0.4 V corresponding to the oxidation of X coupled to the substrate. Integration of the response gives the surface density of the thiol.
- a SAM deposited on gold supported by a quartz crystal is suitable for weighing by the QCM technique.
- reversible redox markers permeation using reversible redox markers.
- the kinetics of the gradual modification of gold by the SAM is followed by the evolution of the cyclo-voltametric signal of simple redox couples known to give a reversible or quasi-reversible signal, such as the Fe (CN) 6 3 ' ' pair. 4 - (hexacyanoferrate ffl / II) or Ru (CN) 6 3 + / 2 + (hexacyanoruthenate IMI).
- the reversibility of the signals is characterized by a separation of the anodic and cathodic oxidation-reduction peaks of the order of 65-80 mV in Tris medium 0.15 M / KC10.5 M pH 7.4.
- the residual current obtained in the presence of a SAM lowers the residual current of the bare surface due to the capacity of the self-assembled molecular layer.
- the typical capacity of the bare double layer, of the order of 20 ⁇ F / cm 2 on bare gold drops to 2 to 6 ⁇ F / cm 2 after modification.
- the capacity of the SAM of the support having the formula of Figure 1 is insensitive to the potential.
- the electrochemical analysis is carried out by means of a device as shown in FIG. 4.
- the electrochemical analysis of the trypsin activity is carried out in a cylindrical polytetrafluoroethylene tank containing 5 ml of 0.15 M Tris buffer. 0.5M KC1 at pH 7.4 using strip 1 as the working electrode, a platinum wire 11 as a counter electrode and an Ag / AgCl 12 electrode as a reference electrode inserted laterally into the vessel, leaving no contact the solution as the tip to minimize protein adsorptions on the glass. It is also possible to put at stake only two electrodes: the working electrode and a silver wire which then acts as a pseudo ⁇ reference, provided that the two electrodes are sufficiently separated so that the phenomena which take place on the counter electrode do not interfere with each other. not with those taking place on the working electrode.
- the surface of the bar, placed horizontally under the tank, is accessible to the solution by a circular view 13 made through the bottom of the tank. Sealing is provided by mechanical pressure exerted by a mechanical clamping system 14 and by interposition of a solvent-resistant polymer O-ring 15 between the tank and the bar.
- the response of the modified surface in the presence of trypsin is obtained by applying a triangular voltammetric signal train between 0.0 and 0.35 V at a rate of 0.1 V / s and periodically at a frequency which depends on the enzyme concentration (between 10 and 300s).
- the maximum potential must not exceed 0.35 V in order to avoid the risk of oxidizing the unhydrolyzed substrate. This limit also aims to not affect the integrity of the SAM.
- the above method and device can be applied to measure other enzymatic activities in a biological fluid, including enzymatic activities related to coagulation of whole blood.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Sustainable Development (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Neurosurgery (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0408960A FR2874385B1 (fr) | 2004-08-18 | 2004-08-18 | Procede et dispositif de mesure d'une activite enzymatique dans un fluide biologique |
PCT/FR2005/002031 WO2006024788A1 (fr) | 2004-08-18 | 2005-08-05 | Procede et dispositif de mesure d'une activite enzymatique dans un fluide biologique |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1781804A1 true EP1781804A1 (fr) | 2007-05-09 |
Family
ID=34950074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05796245A Withdrawn EP1781804A1 (fr) | 2004-08-18 | 2005-08-05 | Procede et dispositif de mesure d'une activite enzymatique dans un fluide biologique |
Country Status (5)
Country | Link |
---|---|
US (1) | US20070269854A1 (fr) |
EP (1) | EP1781804A1 (fr) |
JP (1) | JP2008509693A (fr) |
FR (1) | FR2874385B1 (fr) |
WO (1) | WO2006024788A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI516601B (zh) * | 2007-10-26 | 2016-01-11 | 環球生物醫療感測器私人有限公司 | 電化學檢測之裝置及方法 |
CA2880104A1 (fr) * | 2012-07-27 | 2014-01-30 | Ohmx Corporation | Mesure electrique de monocouches apres detection pro-clivage de la presence et de l'activite d'enzymes et d'autres analytes cibles |
US11932080B2 (en) | 2020-08-20 | 2024-03-19 | Denso International America, Inc. | Diagnostic and recirculation control systems and methods |
US11813926B2 (en) | 2020-08-20 | 2023-11-14 | Denso International America, Inc. | Binding agent and olfaction sensor |
US11760169B2 (en) | 2020-08-20 | 2023-09-19 | Denso International America, Inc. | Particulate control systems and methods for olfaction sensors |
US11828210B2 (en) | 2020-08-20 | 2023-11-28 | Denso International America, Inc. | Diagnostic systems and methods of vehicles using olfaction |
US11760170B2 (en) | 2020-08-20 | 2023-09-19 | Denso International America, Inc. | Olfaction sensor preservation systems and methods |
US11881093B2 (en) | 2020-08-20 | 2024-01-23 | Denso International America, Inc. | Systems and methods for identifying smoking in vehicles |
US12017506B2 (en) | 2020-08-20 | 2024-06-25 | Denso International America, Inc. | Passenger cabin air control systems and methods |
US11636870B2 (en) | 2020-08-20 | 2023-04-25 | Denso International America, Inc. | Smoking cessation systems and methods |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4140662A (en) * | 1977-03-25 | 1979-02-20 | Ortho Diagnostics, Inc. | Attachment of proteins to inert particles |
EP0018002B1 (fr) * | 1979-04-24 | 1983-02-09 | Marcel Jozefonvicz | Procédé pour la détermination de protéases et d'anti-protéases |
US4379780A (en) * | 1980-09-29 | 1983-04-12 | American Home Products Corporation | 17 α-Dihydroequilin hapten and assay method |
US4680338A (en) * | 1985-10-17 | 1987-07-14 | Immunomedics, Inc. | Bifunctional linker |
US5491097A (en) * | 1989-06-15 | 1996-02-13 | Biocircuits Corporation | Analyte detection with multilayered bioelectronic conductivity sensors |
CA2250212C (fr) * | 1996-04-03 | 2010-02-09 | The Perkin-Elmer Corporation | Dispositif et procede de detection d'une pluralite d'analytes |
DE69941563D1 (de) * | 1999-02-23 | 2009-12-03 | Asulab Sa | Elektrochemisches System zur Bestimmung der Blutgerinnungszeit |
US6495336B1 (en) * | 1999-02-23 | 2002-12-17 | Pentapharm Ag | Oligopeptide derivatives for the electrochemical measurement of protease activity |
ES2282150T3 (es) * | 1999-11-15 | 2007-10-16 | I-Stat Corporation | Aparato y metodos para someter a ensayo la coagulacion en muestras de fluidos. |
JP2003524184A (ja) * | 2000-02-21 | 2003-08-12 | エフ.ホフマン−ラ ロシュ アーゲー | 血液凝固測定用の電気化学センサー、対応する血液凝固測定システム、および血液凝固測定方法 |
JP4435454B2 (ja) * | 2001-09-03 | 2010-03-17 | 富士フイルム株式会社 | バイオセンサー用表面 |
-
2004
- 2004-08-18 FR FR0408960A patent/FR2874385B1/fr not_active Expired - Fee Related
-
2005
- 2005-08-05 JP JP2007526506A patent/JP2008509693A/ja active Pending
- 2005-08-05 EP EP05796245A patent/EP1781804A1/fr not_active Withdrawn
- 2005-08-05 US US11/573,797 patent/US20070269854A1/en not_active Abandoned
- 2005-08-05 WO PCT/FR2005/002031 patent/WO2006024788A1/fr active Application Filing
Non-Patent Citations (1)
Title |
---|
See references of WO2006024788A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO2006024788A8 (fr) | 2007-03-15 |
JP2008509693A (ja) | 2008-04-03 |
US20070269854A1 (en) | 2007-11-22 |
FR2874385B1 (fr) | 2006-12-08 |
FR2874385A1 (fr) | 2006-02-24 |
WO2006024788A1 (fr) | 2006-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1781804A1 (fr) | Procede et dispositif de mesure d'une activite enzymatique dans un fluide biologique | |
Bagal-Kestwal et al. | Invertase inhibition based electrochemical sensor for the detection of heavy metal ions in aqueous system: Application of ultra-microelectrode to enhance sucrose biosensor's sensitivity | |
EP0409896B2 (fr) | Electrode enzymatique et son procede de preparation | |
US10307092B2 (en) | Semiconductor based analyte sensors and methods | |
JP4731554B2 (ja) | 被検物センサならびにその製造方法および使用方法 | |
JP5595038B2 (ja) | 分析物センサ装置ならびにその製造方法、組成物及びキット | |
EP0526602B1 (fr) | Capteur de mesure de la quantite d'un composant en solution | |
US20030104119A1 (en) | Microbiosensor | |
Vidal et al. | Amperometric cholesterol biosensor based on in situ reconstituted cholesterol oxidase on an immobilized monolayer of flavin adenine dinucleotide cofactor | |
US20040063167A1 (en) | Minimising calibration problems of in vivo glucose sensors | |
Hayes et al. | Preservation of NADH voltammetry for enzyme-modified electrodes based on dehydrogenase | |
Rahman | Fabrication of mediator-free glutamate sensors based on glutamate oxidase using smart micro-devices | |
Baş et al. | Amperometric biosensors based on deposition of gold and platinum nanoparticles on polyvinylferrocene modified electrode for xanthine detection | |
McMahon et al. | Design variations of a polymer–enzyme composite biosensor for glucose: Enhanced analyte sensitivity without increased oxygen dependence | |
JP2008509693A5 (fr) | ||
EP0276782A2 (fr) | Procédé pour préparer les électrodes d'enzymes | |
Rhemrev-Boom et al. | On-line continuous monitoring of glucose or lactate by ultraslow microdialysis combined with a flow-through nanoliter biosensor based on poly (m-phenylenediamine) ultra-thin polymer membrane as enzyme electrode | |
JPWO2019176339A1 (ja) | バイオセンサプローブ用保護膜材料 | |
EP3283874A1 (fr) | Electrodes de détection électrochimique implantables | |
WO2011064265A1 (fr) | Dispositif électrochimique pour la détermination de propriétés antioxydantes de la peau | |
Rahman et al. | Selective choline biosensors based on choline oxidase co-immobilized into self-assembled monolayers on micro-chips at low potential | |
Compagnone et al. | A new conducting polymer glucose sensor based on polythianaphthene | |
CN113447446B (zh) | 利用斜入射光反射差定量检测还原性多组分生物小分子的芯片及应用和检测方法 | |
Liu et al. | A highly sensitive biosensor with (Con A/HRP) n multilayer films based on layer-by-layer technique for the detection of reduced thiols | |
Portaccio et al. | Amperometric glucose determination by means of glucose oxidase immobilized on a cellulose acetate film: dependence on the immobilization procedures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20070213 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: NIGRETTO, JEAN-MAXIME Inventor name: PARIS, MARIELLE Inventor name: LAMBLIN, GUILLAUME Inventor name: BENATTAR, NORBERT |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: PARIS, MARIELLE Inventor name: NIGRETTO, JEAN-MAXIME Inventor name: LAMBLIN, GUILLAUME Inventor name: BENATTAR, NORBERT |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20081114 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20090526 |